Kyntra Bio, Inc. (KYNB) stock

KYNBNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30

$3.44−0.15 (-4.18%)

Close on Nov 13, 2026Market cap $13.93MP/E 0.1Yield –

Kyntra Bio statistics

82 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Q3 FY2026, expected soon
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $13.93M; $272.32M
Enterprise Value: -$77.39M; $146.23M
PE Ratio: 0.08; 25.11
PS Ratio: 3.02; 3.66

Enterprise valuationIndustry

EV / Sales: -16.76; 2.57

Share statisticsIndustry

Shares Outstanding: 4M; 58M
Shares Change (YoY): 0.30%; 10.8%
Shares Change (QoQ): 0.02%; 0.50%
Float: 3M; 49M
Shares Held by Insiders: 15.7%; 11.7%
Shares Held by Institutions: 24.7%; 56.4%

Short sellingIndustry

Short Interest: 95,811; –
Short Interest Change: 0.87%; -0.80%
Short % of Float: 2.81%; 9.01%
Short % of Shares Outstanding: 2.37%; 6.30%
Days to Cover: 4.68; 5.15

Stock price statisticsIndustry

52-Week High: $10.47; –
52-Week Low: $3.34; –
20-Day Moving Average: $4.34; –
50-Day Moving Average: $5.84; –
200-Day Moving Average: $6.86; –
Average True Range (14): $0.40; –
Price Change (1 Week): -7.77%; -1.15%
Price Change (1 Month): -35.8%; -4.87%
Price Change (3 Months): -49.5%; -21.0%
Price Change (6 Months): -49.6%; -20.6%
Price Change (YTD): -60.8%; -23.6%
Price Change (1 Year): -62.3%; -22.4%
Price Change (3 Years): -71.4%; -29.5%
Price Change (5 Years): -98.9%; -77.9%
Price Change (10 Years): -99.4%; -65.4%
Average Volume (10 Days): 26,007; –
Average Volume (20 Days): 22,986; –
Average Volume (90 Days): 19,733; –
Relative Volume: 0.70; 0.70
Relative Strength Index (14): 23.5; 43.4
Volatility (1 Year): 55.5%; 80.1%
Beta (5 Years): 1.24; 1.07

MarginsIndustry

Gross Margin: 6.26%; 53.1%
Operating Margin: -1089.8%; -38.7%
Pretax Margin: -669.6%; -11.6%
Profit Margin: 3967.8%; -31.6%
EBITDA Margin: -1089.8%; -27.7%
FCF Margin: -824.4%; -9.56%

Returns on capitalIndustry

Return on Assets (ROA): 131.3%; -40.6%
Return on Capital Employed (ROCE): -77.4%; -37.9%

Financial positionIndustry

Current Ratio: 2.69; 3.30
Quick Ratio: 2.54; 2.39
Interest Coverage: -5.42; -6.35

GrowthIndustry

Revenue Growth (YoY): -37.1%; 6.82%
Revenue Growth (3Y CAGR): -64.2%; 2.25%
Revenue Growth (5Y CAGR): -48.4%; 6.41%

EfficiencyIndustry

Asset Turnover: 0.03; 0.40
Inventory Turnover: 1.19; 2.73
Revenue Per Employee: $135.79K; $429.29K
Profits Per Employee: $5.39M; -$689.41K
Employee Count: 34; 74
WACC: 11.3%; 10.2%

Income statement (TTM)Industry

Revenue: $4.62M; $66.37M
Gross Profit: $289.00K; $120.78M
Operating Income: -$50.32M; -$21.37M
Pretax Income: -$30.92M; -$12.95M
Net Income: $183.19M; -$22.35M
EBITDA: -$50.32M; -$17.21M
EPS (Diluted): $45.30; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $91.32M; $68.68M
Net Cash (Debt): $91.32M; $17.76M
Net Cash Per Share: $22.55; $0.80
Equity (Book Value): -$30.14M; $53.89M
Book Value Per Share: -$7.44; $1.50
Tangible Book Value: -$30.14M; $27.13M
Working Capital: $60.79M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$38.05M; -$12.38M
Capital Expenditures: -$9.00K; -$1.00M
Free Cash Flow: -$38.06M; -$18.21M
FCF Per Share: -$9.40; -$0.42

Dividends and yieldsIndustry

Earnings Yield: 1315.2%; -21.8%
FCF Yield: -273.3%; -9.44%

Taxes and interestIndustry

Interest Expense: $9.29M; $2.90M
Income Tax: -$1.00K; $73.00K

Scores and fair valueIndustry

Altman Z-Score: -24.47; 0.23
Piotroski F-Score: 5; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	KYNB	S&P 500	Difference	KYNB per year	S&P 500 per year
1 month	-41.4%	-3.0%	−38.4 pts
3 months	-51.1%	-2.8%	−48.4 pts
Year to date	-60.8%	+11.5%	−72.3 pts
1 year	-62.1%	+13.5%	−75.5 pts
3 years	-66.9%	+77.7%	−144.6 pts	-30.8%	+21.1%
5 years	-98.9%	+72.6%	−171.5 pts	-59.1%	+11.5%
10 years	-99.4%	+308.2%	−407.6 pts	-39.9%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M KYNB shares were sold short on Oct 30, 2026, up 0.9% from the previous report, or 2.81% of the shares available to trade. At recent volumes it would take 4.7 days to buy them back. Over the last 20 sessions, 40.4% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	95,811	+0.9%	20,459	4.7
Oct 15, 2026	94,984	-5.1%	26,762	3.5
Sep 30, 2026	100,040	-0.7%	26,755	3.7
Sep 15, 2026	100,711	-4.8%	23,678	4.3
Aug 31, 2026	105,781	+7.7%	22,838	4.6
Aug 14, 2026	98,197	+0.6%	6,925	14.2
Jul 31, 2026	97,565	-0.1%	5,780	16.9
Jul 15, 2026	97,707	-10.8%	16,256	6.0
Jun 30, 2026	109,506	-4.5%	17,190	6.4
Jun 15, 2026	114,616	-1.6%	50,514	2.3
May 29, 2026	116,425	+2.3%	7,849	14.8
May 15, 2026	113,844	+0.4%	8,640	13.2